CSIMarket


Merion Inc.  (EWLU)
Other Ticker:  
 

Merion Inc.

EWLU's Fundamental analysis








Merion's sales fell by -89.29 % in II. Quarter 2022 from the same quarter a year ago. Ranking at No. 3928

Pharmacy Services & Retail Drugstore industry recorded growth of revenues by 9.51 %

Merion net loss deacreased by in II. Quarter 2022 year on year, Merion net loss increased by -24.14 % in II. Quarter 2022 year on year,

More on EWLU's Growth


Merion
current PE on trailing twelve month basis is above Pharmacy Services & Retail Drugstore industry average.

Merion PEG ratio is at -0.05
Company
PE TTM   
Industry
-
PE TTM    
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.21.


More on EWLU's Valuation
 
 Total Debt (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Merion
current PE on trailing twelve month basis is above Pharmacy Services & Retail Drugstore industry average.

Merion PEG ratio is at -0.05
Company
PE TTM   
Industry
-
PE TTM    
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.21.